Document: HMPC meeting report on European Union herbal monographs, guidelines and other activities - 2-4 March 2026-2026/3/25

Document: Revised rules for reimbursement of expenses for delegates attending meetings-2026/3/25

Page: Eltrombopag product-specific bioequivalence guidance-2026/3/25

Document: Decision of the Executive Director on the access to financial and administrative incentives for micro, small and medium-sized enterprises-2026/3/25

Document: QRD Appendix V - Adverse-drug-reaction reporting details-2026/3/25

Document: QRD Appendix III to the Quality Review of Documents templates for human medicinal products-2026/3/25

Document: QRD Appendix II - Medical Dictionary for Regulatory Activities terminology to be used in section 4.8 'undesirable effects' of the summary of product characteristics (Cover page)-2026/3/25

Document: QRD Appendix II - Medical Dictionary for Regulatory Activities terminology to be used in section 4.8 'undesirable effects' of the summary of product characteristics-2026/3/25

Document: Names of the European Union / European Economic Area countries-2026/3/25

Document: Tables of non-standard abbreviations to be used in the summary of product characteristics-2026/3/25